TickerFactsScreenerDevelopers

Oncotelic Therapeutics, Inc. (OTLC) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$28.67M2010: -$20.43M2011: -$11.78M2012: -$8.34M2013: -$7.00M2017: -$10.93M2018: -$241.0K2019: -$2.28M2020: -$2.81M2021: -$4.43M2022: -$1.45M2023: -$1.32M2024: -$740.3K2025: -$1.38M-$1.38M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$1.38M-86.8%
2024-$740.3K+44.0%
2023-$1.32M+9.1%
2022-$1.45M+67.2%
2021-$4.43M-57.7%
2020-$2.81M-23.3%
2019-$2.28M-846.4%
2018-$241.0K+97.8%
2017-$10.93M—
2013-$7.00M+16.0%
2012-$8.34M+29.3%
2011-$11.78M+42.3%
2010-$20.43M+28.7%
2009-$28.67M—